Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Diseases, Inborn × Alendronate × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Hypogonadism 2 Osteoporosis 1 Neoplasms 1 Neoplasm Metastasis 1 Genetic Diseases, Inborn 1

Interventions

Thalidomide 1 Ketoconazole 1 Docetaxel 1 Alendronate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00019695 2024-03-04

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡